Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients.
Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients. Orca Bio has developed a pipeline of proprietary technologies that have the potential to impact over 100 malignant and auto-immune diseases. Orca has assembled a team of world-leading experts and technologists to execute this vision.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 17, 2020 | Series D | $192M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Kaiser Permanente | — | Series D |
Dream Variation Ventures | — | Series D |